Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/17/1991 | WO1991015579A1 Mutagenesis testing using transgenic non-human animals carrying test dna sequences |
10/17/1991 | WO1991015577A1 INTERLEUKIN 1 beta PROTEASE |
10/17/1991 | WO1991015572A1 Live vaccines |
10/17/1991 | WO1991015571A1 Expression of heterologous protein in yeast |
10/17/1991 | WO1991015514A1 Oxidation resistant thrombomodulin analogs |
10/17/1991 | WO1991015513A1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides |
10/17/1991 | WO1991015501A1 Introducing nucleic acid into animal cells |
10/17/1991 | WO1991015238A1 Methods and compositions for vaccination against hiv |
10/17/1991 | WO1991015237A1 Compositions and treatments for pneumonia in animals |
10/17/1991 | WO1991015234A1 Recombinant bile salt activated lipases |
10/17/1991 | WO1991015233A1 Use of protease nexin-i to mediate wound healing |
10/17/1991 | WO1991015225A1 Multiple sclerosis t-cell receptor |
10/17/1991 | WO1991015116A1 Doubly transgenic animals |
10/17/1991 | WO1991013159A3 Regeneration and genetic transformation of sugar beet |
10/17/1991 | WO1991013075A3 Method and reagent for determining specific nucleotide variations |
10/17/1991 | WO1991011513A3 Catechol-o-methyltransferase, polypeptide sequences and dna molecule coding therefor |
10/17/1991 | WO1991008298A3 Fusion proteins consisting of a ligand binding protein and a stable plasma protein |
10/17/1991 | WO1991006658A3 Infective protein delivery system |
10/17/1991 | WO1991000916A3 Receptors for fibroblast growth factors |
10/17/1991 | DE4111321A1 New alkaline lipase from Bacillus species - used in low temp., washing, cleaning etc. compsns., also encoding deoxyribonucleic acid, vectors and transformed microorganisms |
10/17/1991 | CA2079903A1 Gene therapy for cell proliferative diseases |
10/17/1991 | CA2079792A1 Mutagenesis testing using transgenic non-human animals carrying test dna sequences |
10/17/1991 | CA2079783A1 Use of protease nexin-i to mediate wound healing |
10/17/1991 | CA2079600A1 Interleukin-4 binding protein-gamma |
10/17/1991 | CA2078546A1 Methods and compositions for vaccination against hiv |
10/17/1991 | CA2056439A1 Method for the protection of plants against pathogens |
10/17/1991 | CA2040513A1 Method of diagnosing cancer |
10/17/1991 | CA2039921A1 Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication |
10/16/1991 | EP0452269A2 Tissue-preferential promoters |
10/16/1991 | EP0452224A1 DNA molecule and plasmid containing at least one phage resistance mechanism, bacteria containing them and use therefor |
10/16/1991 | EP0452112A1 Cholesterol oxidase |
10/16/1991 | EP0451896A1 New yeast strains with enhanced trehalose content, process to obtain such yeasts and the use of these yeasts |
10/16/1991 | EP0451878A1 Modifying plants by genetic engineering to combat or control insects |
10/16/1991 | EP0451823A2 DNA constructs for expression of proteins in the lacteal gland of transgenic mammals |
10/16/1991 | EP0451792A1 Regulated gene expression in streptomycetes |
10/16/1991 | EP0451700A1 Recombinant APP minigenes for expression in transgenic mice as models for Alzheimers's disease |
10/16/1991 | EP0451612A1 Anti-oncostatin M monoclonal antibodies |
10/16/1991 | EP0451591A1 Method for specific amplification of RNA templates and for the determination of RNA |
10/16/1991 | EP0451550A2 Seroreactive epitopes of human Papillomavirus (HPV) 16 proteins |
10/16/1991 | EP0451452A1 A recombinant plasmid for lipase expression and a process for producing a lipase |
10/16/1991 | EP0451244A1 Subtilisin mutants |
10/16/1991 | EP0451211A1 Cloning and production of polypeptide analogs of human fibronectin and method of using such polypeptide analogs |
10/16/1991 | EP0451206A1 Receptor transcription-repression activity compositions and methods |
10/16/1991 | EP0451157A1 Transgenic animals for testing multidrug resistance |
10/16/1991 | EP0451141A1 Immobilized sequence-specific probes |
10/16/1991 | EP0423193A4 A method of treating diseases caused by immunodeficiency states by administering human neutrophil chemotactic factor to human |
10/16/1991 | EP0193561B1 Monoclonal antibodies against metal chelates |
10/16/1991 | CN1055389A Novel proteins with oncostatin m activity and process for their preparation |
10/15/1991 | US5057426 Method for separating long-chain nucleic acids |
10/15/1991 | US5057425 Picromycin resistance-conferring gene, designated pica, for use in streptomyces and other organisms |
10/15/1991 | US5057422 Recombinant dna: transformed microorganisms, plant cells and plants: a process for introducing an inducible property in plants, and a process for producing a polypeptide or protein by means of plants or plant cells |
10/15/1991 | US5057420 Bovine nuclear transplantation |
10/15/1991 | US5057417 Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein |
10/15/1991 | US5057416 For polypeptide products |
10/15/1991 | US5057411 For identifying specific viruses |
10/15/1991 | CA1290713C Protein and production thereof |
10/15/1991 | CA1290712C Multidrug resistance in mammalian cell lines and isolation of determinant glycoprotein dna |
10/15/1991 | CA1290664C Solution-phase single hybridization assay for detecting polynucleotide sequences |
10/14/1991 | WO1991016438A1 Dna molecule and plasmid comprising at least one phage resistant mechanism, bacteria containing same and uses thereof |
10/14/1991 | CA2062736A1 Dna molecule and plasmid comprising at least one mechanism for resistance to phages, bacteria containing it, and their use |
10/12/1991 | CA2040178A1 Dna constructs for the expression of proteins in the mammary gland of transgenic mammals |
10/11/1991 | CA2040077A1 Recombinant app minigenes for expression in transgenic mice as models for alzheimer's disease |
10/10/1991 | WO1992017583A1 Isolated viral protein cytokine antagonists |
10/10/1991 | WO1991015503A1 T-cell suppressor protein |
10/10/1991 | WO1991015499A1 2'-o-alkyl nucleotides and polymers containing them |
10/10/1991 | WO1991015226A1 Rejuvenation compositions and methods for their use |
10/10/1991 | DE4037363A1 New 2-O-alkyl nucleotide(s) and polymers contg. them - for nuclease-resistant anti-sense probes and to treat viral infection including herpes influenza and AIDS and cancer |
10/10/1991 | CA2080371A1 T-cell suppressor protein |
10/10/1991 | CA2080336A1 Rejuvenation compositions and methods for their use |
10/09/1991 | EP0450936A1 Monoclonal antibody to avermectins |
10/09/1991 | EP0450931A1 Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies |
10/09/1991 | EP0450920A2 Cloned tyrosine phenol-lyase gene, recombinant plasmid containing it and E. coli transformed with the plasmid |
10/09/1991 | EP0450813A2 Protein phosphatase inhibitor-1 gene and expression |
10/09/1991 | EP0450758A1 An acetyltransferase gene-containing DNA |
10/09/1991 | EP0450594A2 DNA probe signal amplification |
10/09/1991 | EP0450573A2 Antibodies for the treatment and diagnosis of Pseudomonas aeruginosa infections |
10/09/1991 | EP0450430A2 DNA sequence comprising a structural gene coding for xylose reductase or xylose reductase and xylitol dehydrogenase |
10/09/1991 | EP0450386A2 Production of biologically active, recombinant members of the NGF/BDNF family of neurotrophic proteins |
10/09/1991 | EP0450370A1 Branch migration of nucleotides |
10/09/1991 | EP0450048A1 Stable mammalian cell lines that express aromatase |
10/09/1991 | EP0449980A1 Sequential peptide and oligonucleotide synthesis using immunoaffinity techniques |
10/09/1991 | EP0449972A1 Triple stranded nucleic acid and methods of use |
10/09/1991 | EP0449968A1 PROCESS FOR THE PREPARATION OF HUMAN DNase |
10/09/1991 | EP0449956A1 Novel lymphokine/cytokine genes |
10/09/1991 | EP0449948A1 Grafting genetically modified cells to treat diseases of the central nervous system |
10/09/1991 | EP0449856A1 Pneumolysin mutants and pneumococcal vaccines made therefrom |
10/09/1991 | EP0449839A1 Improved bacterial strains for heterologous gene expression |
10/09/1991 | EP0449828A1 HUMAN Fc$g(g) RECEPTOR III |
10/09/1991 | EP0414809A4 Plant defense gene regulatory elements |
10/09/1991 | EP0329736A4 Asexual induction of heritable male sterility and apomixis in plants |
10/09/1991 | CN1055200A Method to build clones with lead-changing penicillium and streptomycete of human tumor necrotic factor (tnf) alpha |
10/08/1991 | US5055553 Low molecular weight pulmonary surfactant proteins |
10/08/1991 | US5055455 Inhibiting adhesion of coagulase-negative staphylococcus to a polymeric material |
10/08/1991 | US5055404 Monoclonal antibody specifically reactive to surface of human prostatic epithelial cells |
10/08/1991 | US5055396 Diagnostic methods and systems for quantifying apo ai |
10/08/1991 | US5055392 Cloning of dna encoding transcription factor s-11 |
10/08/1991 | US5055294 Chimeric bacillus thuringiensis crystal protein gene comprising hd-73 and berliner 1715 toxin genes, transformed and expressed in pseudomonas fluorescens |
10/08/1991 | US5055289 Dual specificity against therapeutically active agent and against a disease related antigen |
10/08/1991 | CA1290267C Human anti-inflammatory phospholipase inhibitor protein |
10/08/1991 | CA1290266C Monoclonal antibodies to unreduced nonenzymatically glycated proteins |